| Lisa Marie Sayoc, MD | |
|
4565 Dressler Nwrd Ll3, Canton, OH 44718-2579 | |
| (330) 491-4700 | |
| (330) 497-0667 |
| Full Name | Lisa Marie Sayoc |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 27 Years |
| Location | 4565 Dressler Nwrd Ll3, Canton, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124095682 | NPI | - | NPPES |
| 2247232 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 350755495 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lisa Marie Sayoc, MD 4565 Dressler Nwrd Ll3, Canton, OH 44718-2579 Ph: (330) 491-4700 | Lisa Marie Sayoc, MD 4565 Dressler Nwrd Ll3, Canton, OH 44718-2579 Ph: (330) 491-4700 |
News Archive
Botulinum neurotoxin is probably best known to Americans as BOTOX, a cosmetic medicine, rather than as a cause of potentially dangerous foodborne illnesses.
Pandemrix is an influenza vaccination, created in 2009 to combat H1N1, known as Swine Flu. Now, a team of Swedish clinicians testing the vaccine for links to immune-related or neurological diseases have linked Pandemrix to an increased risk of narcolepsy in young adults.
Future Science Group today announced that it will provide free access to three of its peer-reviewed, cancer-focused journals for the remainder of 2015.
Pfizer Inc. announced today that it has stopped a Phase 3 clinical trial of Lyrica (pregabalin) in patients with neuropathic pain associated with HIV neuropathy, a form of nerve damage characterized by burning pain usually beginning in the feet. The decision follows review of a planned interim analysis of the study by the trial's external Data Monitoring Committee.
Charles River Laboratories International, Inc. announced today that it has implemented an accelerated stock repurchase (ASR) program to repurchase $300 million of common stock, as part of its previously announced authorization from its Board of Directors to repurchase up to $500 million of common stock. The new ASR program will enable the Company to facilitate, on a more timely and cost efficient basis, the repurchase of a substantial number of its shares pursuant to that stock repurchase authorization.
› Verified 6 days ago
Dr. Alison Bates Durham, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4124 Munson St Nw, Canton, OH 44718 Phone: 440-443-0423 Fax: 440-443-0414 | |
Schield M Wikas, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4240 Munson St Nw Ste C, Canton, OH 44718 Phone: 330-492-2327 Fax: 330-492-0953 | |
Dr. Maria A Charif, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4340 Fulton Dr Nw, Canton, OH 44718 Phone: 330-244-8886 Fax: 330-244-8869 | |
Dr. Fausto Antonio Sicard, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4825 Munson St Nw, Canton, OH 44718 Phone: 330-497-7525 | |
Mr. Mark William Berbaum, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 4527 Everhard Rd Nw, Canton, OH 44718 Phone: 330-966-3111 Fax: 330-966-1416 | |
Monte E Fox, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4240 Munson St Nw Ste C, Canton, OH 44718 Phone: 330-492-2327 Fax: 330-492-0953 |